SEOUL: SK bioscience, the biopharmaceutical arm of South Korea's SK Group, said on Wednesday it has achieved a "final victory" in a patent invalidation case against Moderna, the global developer of ...

(Reuters) -Moderna on Thursday ... demand for its COVID-19 vaccine. The U.S. vaccine maker also said it did not expect to get regulator approval for its combination shot to protect against both ...

SAN CARLOS, Calif. - BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), soon to be known as BeOne Medicines Ltd., has successfully challenged a competitor’s patent, leading to a U.S. Patent and ...

In a significant development for BeiGene , Ltd. (NASDAQ:BGNE), a biotechnology company with impressive 54.96% revenue growth over the last twelve months, the U.S. Patent and Trademark Office ...

Novavax’s shot uses traditional protein-based vaccine technology and is the only alternative to the mRNA shots from Pfizer and Moderna ... to target a more recent Covid variant called JN.1 ...

A Vietnam veteran was awarded $25,000 on Friday after he alleged a now-closed inflatable play center inside the Nittany Mall violated disability law by denying him entry with his service dog ...

This patent grant enhances RedHill's strategic positioning in the global COVID-19 therapeutic space, a market still expected to be worth more than $3 billion in 2025 [1], and expands its patent ...

Federal regulators are asking Novavax NVAX-10.29%decrease; red down pointing triangle to complete an additional randomized clinical trial on its Covid-19 vaccine after previously delaying approval ...

Novo Nordisk (NVO) won a key case Thursday to stop some compounding pharmacies from selling knockoff versions of its blockbuster GLP-1 drugs. But it won't end all compounding offerings.

Jenna Sundel is a Newsweek reporter based in New Jersey. Her focus is reporting on breaking news. She has in-depth knowledge of crime and courts. Jenna joined Newsweek in 2024. She previously ...